QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Range

143.01 - 150.19

Vol / Avg.

474.8K/512.5K

Div / Yield

-

52 Wk

103.31 - 265

Mkt Cap

6.2B

Payout Ratio

-

Open

147

P/E

7.22

EPS

5.17

Shares

41.7M

Outstanding

41.7M

Total Float

32.3M

Analyst Ratings

The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case

Benzinga - 4 days ago

Quidel Q3 EPS $5.36 Beats $3.52 Estimate, Sales $509.74M Beat $376.81M Estimate

Benzinga - Nov 4, 2021, 5:36PM

Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected

Benzinga - Oct 8, 2021, 1:08PM

Quidel shares are trading higher after the company issued Q3 sales guidance and reported it shipped over 45 million SARS tests over the quarter.

Benzinga - Oct 7, 2021, 4:18PM

Quidel Sees Q3 Sales $505M-$510M, Shipped 45M+ SARS Tests Over Quarter

Benzinga - Oct 7, 2021, 4:11PM

White House COVID-19 Coordinator Zients Says U.S. Making Further $1B Investment In Testing To Buy Additional 180M Tests

Benzinga - Oct 6, 2021, 3:11PM

White House Advisor ZIents Says Quidel, OraSure Are Further/More Rapidly Expanding Production Of Their Tests To Get More Capacity Of The Market

Benzinga - Oct 6, 2021, 3:10PM

FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations

Benzinga - Sep 24, 2021, 1:21PM

Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy

Benzinga - Sep 2, 2021, 8:19AM

Raymond James Maintains Outperform on Quidel, Raises Price Target to $155

Benzinga - Aug 6, 2021, 12:20PM

Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales

Benzinga - Aug 6, 2021, 8:03AM

Quidel shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results. The company reported Q2 sales of COVID-related products fell from $109 million to $83.4 million.

Benzinga - Aug 6, 2021, 7:59AM

Quidel Q2 Sales Of COVID-Related Products Fell From $109M To $83.4M YoY

Benzinga - Aug 5, 2021, 4:13PM

Quidel Q2 Adj. EPS $0.75 Misses $1.46 Estimate, Sales $176.60M Miss $194.50M Estimate

Benzinga - Aug 5, 2021, 4:13PM

Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation And Transitions BNP Business To Beckman Coulter; Co. To Receive Cash Payments $70M-$75M Per Year Through 2029

Benzinga - Jul 26, 2021, 8:32AM

OraSure Shares Spike Higher; Traders Circulate TradeTheNews Rumor Co Rebuffs Quidel Takeover Offer And Explores Options

Benzinga - Jul 19, 2021, 12:52PM

Quidel Says State Of Delaware Selects Co For COVID-19 Testing Program At Schools; Terms Not Disclosed

Benzinga - Jul 19, 2021, 10:30AM

Quidel Says Receives CE Mark For Savanna Multiplex Molecular Analyzer And Respiratory Viral Panel

Benzinga - Jul 12, 2021, 9:16AM

load more

Sector: Health Care.Industry: Health Care Equipment & Supplies

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Earnings

Q4 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2022-02-17
REV		(EXPECTED)2022-02-17

Q3 2021		Est.		Actual		Surprise
EPS		3.520		5.360		1.8400
REV		376.810M		509.736M		132.926M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Quidel Questions & Anwsers

Q

How do I buy Quidel (QDEL) stock?

A

You can purchase shares of Quidel (NASDAQ: QDEL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Quidel's (QDEL) competitors?

A

Other companies in Quidel’s space includes: RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Meridian Bioscience (NASDAQ:VIVO), BioLife Solutions (NASDAQ:BLFS) and Align Tech (NASDAQ:ALGN).

Q

What is the target price for Quidel (QDEL) stock?

A

The latest price target for Quidel (NASDAQ: QDEL) was reported by Raymond James on August 6, 2021. The analyst firm set a price target for 155.00 expecting QDEL to rise to within 12 months (a possible 4.77% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Quidel (QDEL)?

A

The stock price for Quidel (NASDAQ: QDEL) is $147.95 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Quidel (QDEL) pay a dividend?

A

There are no upcoming dividends for Quidel.

Q

When is Quidel (NASDAQ:QDEL) reporting earnings?

A

Quidel’s $Q4 earnings are confirmed for after-market on February 17, 2022.

Q

Is Quidel (QDEL) going to split?

A

There is no upcoming split for Quidel.

Q

What sector and industry does Quidel (QDEL) operate in?

A

Quidel is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.